Related Experiment Video
Updated: May 31, 2026

Aip1p Dynamics Are Altered by the R256H Mutation in Actin
Published on: July 30, 2014
The effect of the dilated cardiomyopathy-causing Glu40Lys TPM1 mutation on actin-myosin interactions during the
Yurii S Borovikov1, Stanislava V Avrova, Olga E Karpicheva
1Laboratory of Mechanisms of Cell Motility, Institute of Cytology, Russian Academy of Sciences, 4 Tikhoretsky Avenue, St. Petersburg 194064, Russia. boroviko@mail.cytspb.rssi.ru
Insights
Dilated cardiomyopathy (DCM) is linked to a mutation in cardiac α-tropomyosin (TM). This mutation impairs actomyosin interactions, leading to reduced muscle contraction and heart failure.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Research
Background:
- Dilated cardiomyopathy (DCM) causes heart failure due to cardiac dysfunction.
- Mutations in the cardiac α-tropomyosin (TM) gene are a known cause of DCM.
- Understanding the molecular mechanisms of TM mutations is crucial for treating heart failure.
Purpose of the Study:
- To investigate how the Glu40Lys mutation in α-tropomyosin (TM) affects actomyosin interactions.
- To elucidate the impact of the Glu40Lys mutation on the dynamics of actin and myosin during the ATP hydrolysis cycle.
- To correlate structural changes with contractile deficits in dilated cardiomyopathy.
Main Methods:
- Reconstitution of thin filaments in muscle ghost fibers with labeled actin and myosin subfragment-1.
- Incorporation of wild-type or Glu40Lys mutant α-tropomyosin (TM).
- Utilized polarized fluorimetry to directly measure the mobility and rotation of actin subdomain-1 and myosin SH1 helix.
Main Results:
- The Glu40Lys mutant TM significantly inhibited the movement of actin and myosin during the ATP hydrolysis cycle.
- Specifically, movements were hindered during the transition from the AM(∗∗)·ADP·Pi to the AM state.
- This inhibition suggests a reduced proportion of strong-binding states within the actomyosin population.
Conclusions:
- The Glu40Lys mutation in α-tropomyosin disrupts normal actomyosin dynamics.
- These disruptions in protein movement are likely responsible for the impaired muscle contraction seen in dilated cardiomyopathy.
- Findings provide molecular insights into the pathogenesis of DCM caused by TM mutations.
Abstract:
Dilated cardiomyopathy (DCM), characterized by cardiac dilatation and contractile dysfunction, is a major cause of heart failure. DCM can result from mutations in the gene encoding cardiac α-tropomyosin (TM). In order to understand how the dilated cardiomyopathy-causing Glu40Lys mutation in TM affects actomyosin interactions, thin filaments have been reconstituted in muscle ghost fibers by incorporation of labeled Cys707 of myosin subfragment-1 and Cys374 of actin with fluorescent probe 1.5-IAEDANS and α-tropomyosin (wild-type or Glu40Lys mutant). For the first time, the effect of these α-tropomyosins on the mobility and rotation of subdomain-1 of actin and the SH1 helix of myosin subfragment-1 during the ATP hydrolysis cycle have been demonstrated directly by polarized fluorimetry. The Glu40Lys mutant TM inhibited these movements at the transition from AM(∗∗)·ADP·Pi to AM state, indicating a decrease of the proportion of the strong-binding sub-states in the actomyosin population. These structural changes are likely to underlie the contractile deficit observed in human dilated cardiomyopathy.
Related Concept Videos
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
ATP Synthase: Mechanism
Actin and Myosin in Muscle Contraction
Actin Treadmilling
ATP Synthase: Structure
The Role of Actin and Myosin in Non-muscle Cells
